Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Styczynski

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
Haematologica|June 24, 2021
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file studyHildegard T Greinix, Dirk-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation|November 5, 2023
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trialKarl-Walter Sykora, Rita Beier, Ansgar Schulz, et al.
Bone Marrow Transplantation|May 23, 2021
Legionellosis after hematopoietic stem cell transplantationMalgorzata Mikulska, Gloria Tridello, Jennifer Hoek, et al.
Bone Marrow Transplantation|March 24, 2020
Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignanciesKrzysztof Kalwak, Monika Mielcarek, Katharine Patrick, et al.
Bone Marrow Transplantation|April 7, 2019
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019Rafael F Duarte, Myriam Labopin, Peter Bader, et al.
Blood|December 14, 2011
Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party studyJan Styczynski, Adriana Balduzzi, Lidia Gil, et al.
Complementary Therapies in Medicine|April 13, 2013
Use of complementary and alternative medicine by children in Europe: published data and expert perspectivesTycho J Zuzak, Johanna Boňková, Domenico Careddu, et al.
Mycoses|February 4, 2020
Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM surveyFanny Lanternier, Danila Seidel, Livio Pagano, et al.
Transplantation and Cellular Therapy|April 15, 2024
Listeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow TransplantationDina Averbuch, Gloria Tridello, Lotus Wendel, et al.
Journal of Neurology|October 31, 2019
Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMTMartin Schmidt-Hieber, Dan Engelhard, Andrew Ullmann, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Haematologica|June 24, 2021
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file studyHildegard T Greinix, Dirk-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation|November 5, 2023
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trialKarl-Walter Sykora, Rita Beier, Ansgar Schulz, et al.
Bone Marrow Transplantation|May 23, 2021
Legionellosis after hematopoietic stem cell transplantationMalgorzata Mikulska, Gloria Tridello, Jennifer Hoek, et al.
Bone Marrow Transplantation|March 24, 2020
Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignanciesKrzysztof Kalwak, Monika Mielcarek, Katharine Patrick, et al.
Bone Marrow Transplantation|April 7, 2019
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019Rafael F Duarte, Myriam Labopin, Peter Bader, et al.
Blood|December 14, 2011
Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party studyJan Styczynski, Adriana Balduzzi, Lidia Gil, et al.
Complementary Therapies in Medicine|April 13, 2013
Use of complementary and alternative medicine by children in Europe: published data and expert perspectivesTycho J Zuzak, Johanna Boňková, Domenico Careddu, et al.
Mycoses|February 4, 2020
Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM surveyFanny Lanternier, Danila Seidel, Livio Pagano, et al.
Transplantation and Cellular Therapy|April 15, 2024
Listeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow TransplantationDina Averbuch, Gloria Tridello, Lotus Wendel, et al.
Journal of Neurology|October 31, 2019
Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMTMartin Schmidt-Hieber, Dan Engelhard, Andrew Ullmann, et al.
Pageof 16